Meeting the Future Needs of a Changing Community
iBIO is excited to release our 2019 State of the Industry Report, titled Meeting the Future Needs of a Changing Community.
The NIH National Center for Advancing Translational Sciences (NCATS)is seeking applicants for its small business funding opportunities through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. NCATS offers annual funding for the development of innovative tools, technologies and intervention (drug, device, diagnostic) platforms that would support the creation of novel therapeutics.
IBIO has partnered to provide support and monthly reports on non-dilutive financing and government funding for entrepreneurs and researchers running startups in Illinois.
Every month we will release a comprehensive list of non-dilutive government funding opportunities. We will also be offering regular updates and webinars for new funding sources, agency priorities, conferences where companies can present and meet program managers, advice on how to build those relationships and insights on the process.
To stay updated on these opportunities and other community programs and news, subscribe to iBIO’s Daily NewsBrief:
Last week, iBIO organized a trip to Washington for Illinois medical technology (MedTech) companies to meet with lawmakers and discuss how they can work together to provide patients greater access to next generation, life-saving products.
Today, iBIO announced that Horizon Pharma, a global biopharmaceutical company, has made a donation to support iBIO’s Charitable Programs working to diversify the STEM talent pipeline. The donation will support two main programs focused on increasing interest in STEM in underserved communities for girls grades 3-8.
The Exploring Global Challenges partnership with Southern Illinois University is funded by the National Science Foundation and is building computational thinking into the StellarGirls Program. The partnership was featured in the East St. Louis news: STEM+C After-School Initiative inspires minority girls to solve global challenges
Our broad portfolio of cost-saving programs keeps costs down so that companies can reinvest in
themselves! As the largest cost-savings program in the life sciences industry, BIO Business Solutions®™
offers iBIO members exclusive access to savings on the products and services you need to run a successful
biotech enterprise. Our programs are designed to save you time and money so you can focus your
resources on your research efforts. Don’t just take out word for it—Hear how BIO Business Solutions®
helped one BIO member save on business essentials!
Sponsor: Rep. Michelle Mussman (D)
Creates the Digital Fair Repair Act. Provides that original equipment manufacturers shall: (i) make available to any independent repair provider or owner of equipment manufactured by the original equipment manufacturer the same diagnostic and repair documentation in the same manner as that information is made available to the manufacturer’s authorized repair providers; and (ii) make available for purchase by the owner, his or her authorized agent, or any independent repair provider parts, inclusive of any updates to the embedded software of the parts, upon fair and reasonable terms. Requires original equipment manufacturers to make available for purchase by owners and independent repair providers all diagnostic repair tools incorporating the same diagnostic, repair, and remote communications capabilities that the original equipment manufacturer makes available to its own repair or engineering staff or an authorized repair provider. Requires an independent repair provider that purchases or acquires embedded software or service parts to notify the owner of the equipment in writing of certain warranties prior to performing any services on digital electronic equipment. Provides that, with one exception, an authorized provider shall have all the rights and remedies provided under the Act. Authorizes the Attorney General to seek to enjoin violations and to recover civil penalties. Requires the Attorney General to establish an outreach program to inform the public of rights under the Act. Defines terms. Excludes motor vehicle manufacturers. Provides for recovery of damages and attorney’s fees. Provides for the protection of trade secrets. Effective January 1, 2020.
Primary Sponsor: Representative Mary E. Flowers (D)
Creates the Medical Device Safety Act. Provides that (i) all medical devices to be used by, surgically applied to, or surgically implanted within a patient be under warranty, regardless of the severity of the patient’s medical condition necessitating the device, (ii) all persons and entities that produce, sell, offer for sale, or provide medical devices to be used by, surgically applied to, or surgically implanted within a patient are liable for all costs to the patient for the replacement of each medical device if the medical device malfunctions due to no fault of the patient, and (iii) all hospitals and ambulatory surgical treatment centers shall waive the costs charged to patients for followup surgeries that result from defective medical devices, regardless of whether or not those defective medical devices are capable of being implanted. Amends the University of Illinois Hospital Act, the Ambulatory Surgical Treatment Center Act, and the Hospital Licensing Act. Requires that the University of Illinois Hospital, all ambulatory surgical treatment centers, and all hospitals licensed under the Hospital Licensing Act waive the costs charged to patients for followup surgeries that result from previous surgical errors. Effective immediately.